UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum.

par Michel, Uwe, Kallmann, Boris, Rieckmann, Peter, Isbrandt, Dirk
Publié 2002

Escalating Immunotherapy of Multiple Sclerosis

par Rieckmann, Peter, Traboulsee, Anthony, Devonshire, Virginia, Oger, Joel
Publié 2008

The Changes of P-glycoprotein Activity by Interferon-γ and Tumor Necrosis Factor-α in Primary and Immortalized Human Brain Microvascular Endothelial Cells

par Lee, Na-Young, Rieckmann, Peter, Kang, Young-Sook
Publié 2012

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis

par Metz, Imke, Rieckmann, Peter, Kallmann, Boris-Alexander, Brück, Wolfgang
Publié dans Acta Neuropathol Commun (2016)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier

par Yeandle, David, Rieckmann, Peter, Giovannoni, Gavin, Alexandri, Nektaria, Langdon, Dawn
Publié dans Neurol Ther (2018)

SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties

par Alkabie, Samir, Basivireddy, Jayasree, Zhou, Lixin, Roskams, Jane, Rieckmann, Peter, Quandt, Jacqueline A.
Publié dans J Neuroinflammation (2016)

Excitability decreasing central motor plasticity is retained in multiple sclerosis patients

par Zeller Daniel, Dang Su-Yin, Weise David, Rieckmann Peter, Toyka Klaus V, Classen Joseph
Publié 2012-09-01

Excitability decreasing central motor plasticity is retained in multiple sclerosis patients

par Zeller, Daniel, Dang, Su-Yin, Weise, David, Rieckmann, Peter, Toyka, Klaus V, Classen, Joseph
Publié 2012

Multiple sclerosis in the Arabian Gulf countries: a consensus statement

par Bohlega, Saeed, Inshasi, Jihad, Al Tahan, Abdel Rahman, Madani, Abu Bakr, Qahtani, Hussien, Rieckmann, Peter
Publié 2013

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing m...

par Rieckmann, Peter, Heidenreich, Fedor, Sailer, Michael, Zettl, Uwe K., Zessack, Norbert, Hartung, Hans-Peter, Gold, Ralf
Publié 2012

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

par Vordermark, Dirk, Ruprecht, Klemens, Rieckmann, Peter, Roggendorf, Wolfgang, Vince, Giles H, Warmuth-Metz, Monika, Kölbl, Oliver, Flentje, Michael
Publié 2006

Multiple Sclerosis Registry in Germany: Results of the Extension Phase 2005/2006

par Flachenecker, Peter, Stuke, Kristin, Elias, Wolfgang, Freidel, Matthias, Haas, Judith, Pitschnau-Michel, Dorothea, Schimrigk, Sebastian, Zettl, Uwe K., Rieckmann, Peter
Publié 2008

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

par Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Publié dans Mult Scler (2018)

Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown

par Haarmann, Axel, Deiß, Annika, Prochaska, Jürgen, Foerch, Christian, Weksler, Babette, Romero, Ignacio, Couraud, Pierre-Olivier, Stoll, Guido, Rieckmann, Peter, Buttmann, Mathias
Publié 2010

Expert opinion on the use of cladribine tablets in clinical practice

par Sørensen, Per Soelberg, Centonze, Diego, Giovannoni, Gavin, Montalban, Xavier, Selchen, Daniel, Vermersch, Patrick, Wiendl, Heinz, Yamout, Bassem, Salloukh, Hashem, Rieckmann, Peter
Publié dans Ther Adv Neurol Disord (2020)

Downregulation of CXCR1 and CXCR2 Expression on Human Neutrophils by Helicobacter pylori: a New Pathomechanism in H. pylori Infection?

par Schmausser, Bernd, Josenhans, Christine, Endrich, Simon, Suerbaum, Sebastian, Sitaru, Cassian, Andrulis, Mindaugas, Brändlein, Stephanie, Rieckmann, Peter, Müller-Hermelink, Hans Konrad, Eck, Matthias
Publié 2004

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

par Rieckmann, Peter, Boyko, Alexey, Centonze, Diego, Coles, Alasdair, Elovaara, Irina, Havrdová, Eva, Hommes, Otto, LeLorier, Jacques, Morrow, Sarah A., Oreja-Guevara, Celia, Rijke, Nick, Schippling, Sven
Publié 2012

Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries

par Aljumah, Mohammed, Alroughani, Raed, Alsharoqi, I., Bohlega, Saeed A., Dahdaleh, Maurice, Deleu, Dirk, Esmat, Khaled, Khalifa, Ahmad, Sahraian, Mohammad A., Szólics, Miklós, AlTahan, Abdulrahman, Yamout, Bassem I., Rieckmann, Peter, Daif, Abdulkader
Publié 2013

EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units

par Kam-Thong, Tony, Czamara, Darina, Tsuda, Koji, Borgwardt, Karsten, Lewis, Cathryn M, Erhardt-Lehmann, Angelika, Hemmer, Bernhard, Rieckmann, Peter, Daake, Markus, Weber, Frank, Wolf, Christiane, Ziegler, Andreas, Pütz, Benno, Holsboer, Florian, Schölkopf, Bernhard, Müller-Myhsok, Bertram
Publié 2011

Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know

par AlJumah, Mohamed, Alkhawajah, Mona Marwan, Qureshi, Shireen, Al-Thubaiti, Ibtisam, Ayoub, Omar, Bohlega, Saeed A., Bushnag, Areej, Cupler, Edward, Daif, Abdulkader, El Boghdady, Ahmed, Hassan, Ahmed, Al Malik, Yaser, Saeedi, Jameelah, Al-Shamrany, Fawzia, Shosha, Eslam, Rieckmann, Peter
Publié dans Neurol Ther (2020)